A CRISPR-like enzyme system uses programmable proteins to target and edit specific DNA or RNA sequences. Researchers deploy it for gene therapy, diagnostics, and crop improvement, while clinicians and biotech firms benefit from precise, affordable genetic modifications. Patients with inherited diseases and agricultural producers gain the most, as the technology enables faster, more accurate interventions than traditional methods.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends